M ast cells (MCs) are particularly abundant at the surfaces of contact between the body and the external environment where they act as "sentinels" of tissue and immune homeostasis (1) . MCs function at the crossroad between innate and adaptive immunity, exerting both effector and immunoregulatory roles, depending on their activation status and on the immunological context (2) . MCs express a broad array of soluble and membrane-bound molecules that enable the cross talk with many immune cells of which they influence phenotype and function (3, 4) . MCs prime and regulate adaptive responses by either inducing effector T cells or modulating regulatory T cell suppression (5) . In contrast with the well-defined role for MCs in regulating T cell function, little is known about the interaction of MCs with B cells. Although the B-MC interaction has long been considered as likely and worthy of investigation (6, 7) , only recently has this line of research been more fully explored.
B lymphocytes were traditionally considered effector cells given their ability to produce Abs. Nonetheless, recent findings from several groups revealed the existence of phenotypically diverse B cell subsets with a regulatory suppressive function in various models of chronic inflammation and autoimmune disease (8) . The most widely studied and best understood mechanism by which B lymphocytes accomplish immunosuppression is through secretion of IL-10 (9). In mice, B cells that are competent to express Il-10 are found in different tissues, although at very low frequencies. The majority of these cells do not produce detectable cytoplasmic IL-10, but they do so after 5 h of in vitro stimulation with LPS, PMA, and ionomycin (10) . Therefore, the subset of B cells capable of producing IL-10 after this in vitro stimulation has been labeled as IL-10 competent. Several studies have shown that upon activation, IL-10-competent B cells exert regulatory suppressive functions (11) , and that stimulation through CD40 is essential for their induction (12) .
We have previously demonstrated that MCs can enhance the proliferation and survival of B cells, and drive their functional differentiation toward IgA-secreting plasma cells through CD40L stimulation and IL-6 release (13) . In light of these findings, we hypothesized that, similar to their interaction with T cells (5) , MCs may selectively regulate distinct B cell subsets. In this article, we demonstrate that MCs can expand IL-10-competent B cells and that this expansion is reduced by impairing the CD40L/CD40 axis. Moreover, the analysis of CD19 + IL-10 + cells in different organs of wild-type (WT) and MC-deficient mice revealed that the absence of MCs negatively affects IL-10-competent B cell differentiation, and this can be seen as a very relevant observation in the context of immunologically mediated inflammatory reactions.
Materials and Methods

Mice
Female C57BL/6 (B6) mice were from Harlan Laboratories. C57BL/ 6-Kit W-sh/W-sh (Kit W-sh ) mice were from The Jackson Laboratory and were maintained under specified pathogen-free conditions at the animal facility of Fondazione IRCCS INT, Milan, Italy, in collaboration with the group of M. Colombo. Four-to 6-wk-old female Kit W-sh mice were reconstituted by i.p. injection of 5 3 10 6 in vitro differentiated bone marrow MCs derived from B6 or Cd40l 2/2 mice. Experiments were initiated 8-10 wk later. All animal experiments were performed in accordance with the animal care and use committees of the respective institutes.
Dextran sodium sulfate-induced colitis
To induce colon inflammation, we administered 1.5% dextran sodium sulfate (DSS; m.w. 40.000-50.000; Affymetrix) to WT and Kit W-sh mice in place of normal drinking water for 10 d. Inflammation progression was monitored up to 7 d after DSS withdrawal (day 17). To perform histological analyses, we dissected colons from mice at three different time points: steady-state (day 0), acute inflammation (day 10), and recovery from inflammation (day 17).
Abs
Fluorescence-conjugated Abs to CD1d (1B1), CD19 (6D5), CD40L (MR1), and IL-10 (JES5-16E3) were from BioLegend. PE-Cy7 anti-CD5 (53-7.3) and allophycocyanin anti-CD9 (KMC8) were from eBioscience. Allophycocyanin anti-CD21/CD35 (7G6) was from BD Pharmingen; Alexa Fluor 647 anti-CD23 (B3B4) was from AbD Serotec. Alexa 488 goat antirat and Alexa 568 goat anti-mouse Abs were from Molecular Probes. Unconjugated anti-CD45RA (MEM 56) and anti-IL-10 (JES5-16E3) Abs were, respectively, from Merck Millipore and Novus Biologicals. AntiHsp60 (LK-2) and anti-Hsc70 (1B5) Abs were purchased from Abcam, whereas the anti-TATA-binding protein (TBP, clone 58C9) Ab was from Sigma-Aldrich and the anti-ATP5B (3D5) Ab from Santa Cruz. Ascites containing the anti-CD40L (MR1) Ab were a gift of M. Colombo.
Cell preparation
Purified splenic B cells were obtained from 6-to 12-wk-old B6 mice as previously described (14) . Bone marrow-derived MCs (BMMCs) were obtained by in vitro differentiation of bone marrow cells taken from femurs of B6 WT or Cd40l 2/2 mice as previously described (15) . Lymph node cells were purified from either axillary or inguinal lymph nodes by gently disrupting the lymph node in PBS using the sterile plunger of a 1-ml syringe. Peritoneal cells were obtained injecting cold PBS supplemented with 3% FBS in the peritoneal cavity and dislodging any attached cell by massaging the peritoneum. The peritoneal B cell population was enriched by performing an adhesion step of at least 1 h in a six-well flat-bottom culture plate and by collecting only the nonadherent cells. Colonic lamina propria (LP) cells were isolated as described previously (16) , through two sequential incubations of 30 min each with, respectively, 1.5 mg/ml Dispase (Life Technologies) and 1.0 mg/ml Dispase plus 1.5 mg/ml collagenase type II (Life Technologies). The obtained cell population was enriched in B and T lymphocytes (B cells were 20% of the enriched lymphocyte population) through Percoll gradient (45-72%) centrifugation.
B-MC coculture conditions
Purified splenic B cells were cultured for 48 h with an equal number of IgEsensitized or nonsensitized MCs, in the presence or absence of 100 ng/ml DNP-human serum albumin (Sigma-Aldrich). To study the role of MCs on B lymphocytes from the peritoneum and colonic LP, we cultured 0.6 3 10 6 MCs with an equal number of total peritoneal or colonic cells, enriched in B lymphocytes as described earlier. To evaluate the role of the CD40L/ CD40 axis, we added an ascites containing the anti-CD40L blocking Ab to culture medium at 50 mg/ml and maintained it for all 48 h of culture. In some experiments, B cells and MCs were separated by a transwell (Corning Costar) with pores of 0.4 mm. A total of 0.6 3 10 6 B cells was cultured in the bottom chamber in 0.7 ml medium while 0.2 3 10 6 MCs were placed in the top chamber, in a final volume of 0.2 ml. For proliferation assays, B cells were stained with Cell Proliferation Dye eFluor 670 (CPD; eBioscience) before coculture with MCs for 72 h.
Detection of intracellular and secreted IL-10
For immunofluorescent staining of IL-10, cells were resuspended in medium containing 10 mg/ml LPS, 50 ng/ml PMA, 500 ng/ml ionomycin, 2 mM monensin (all from Sigma-Aldrich) and cultured for 5 h at 37˚C. The protocol for intracellular staining was as described previously (10) . In certain experiments, Alexa Fluor 647 anti-CD23, FITC anti-CD5, allophycocyanin anti-CD21/CD35 and Alexa Fluor 647 anti-CD23 or PE-Cy7 anti-CD5 and Pacific Blue anti-CD1d were used to assess the expression of surface markers other than CD19. Stained samples were acquired on FACScan (BD Biosciences), FACSCalibur (BD Biosciences), or Cyan ADP nine-color cytometer (DakoCytomation). Data were analyzed with FlowJo software.
IL-10 levels in cell supernatants were quantified by ELISA. A total of 0.6 3 10 6 B cells and MCs was seeded, either alone or together, in 0.6 ml medium and cultured for 48 h. The mouse IL-10 ELISA Ready-SET-Go kit (eBioscience) was used, following manufacturer's instructions.
Purification and analysis of exosomes from cell culture supernatants
A total of 5 3 10 6 B cells and MCs was cultured either alone or together in 5 ml medium for 48 h. Culture media were collected and centrifuged at 300 3 g for 10 min. Cleared supernatants were incubated with 1 ml ExoQuick-TC Exosome Precipitation Solution (System Biosciences) overnight (o/n) at 4˚C for precipitation. The exosome-containing pellet was resuspended in PBS and stored at 280˚C until use for analysis. For flow cytometry experiments, isolated exosomes were incubated with 4-mm diameter aldehyde/sulfate latex beads (Interfacial Dynamics; 10 ml in 0.3 ml PBS), o/n, at room temperature, under gentle movement. Samples were saturated with 1 M glycine, washed, and stained with specific Abs. Samples were acquired on FACSCalibur and analyzed by Summit v4.3 software (Dako Cytomation). For Western blot experiments, exosomes were lysed in radioimmunoprecipitation assay buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS) and mixed with Laemmli buffer. Protein extracts were separated on 12% SDS-PAGE, samples were transferred onto nitrocellulose membranes, and Western blot analyses were performed using specific anti-Hsp60, antiHsc70, anti-TBP, or anti-ATP5B Abs. HRP-conjugated secondary Abs were revealed using chemiluminescence substrate (Pierce). Blots were captured by using a ChemiDoc XRS imaging system (Bio-Rad), and signals were quantified with the instrument bundled densitometric software.
Real-time video microscopy and conjugate formation evaluation
The formation of MC-B cell conjugates in real time was analyzed by timelapse epiluminescent microscopy as previously described (17) . At different time points the number of MCs in contact with B cells was counted and the percentage of B-conjugated MCs over total MCs per field was calculated.
Immunofluorescence microscopy
Tissue samples were fixed in 10% buffered formalin and paraffin embedded. For immunofluorescence analysis, tissue sections were deparaffinized with xylene and rehydrated to water through a graded alcohol series. Hightemperature Ag unmasking was performed using citrate buffer pH 6 (Novocastra) in a water bath at 98˚C for 30 min. Subsequently, the sections were brought to room temperature and washed in PBS. After Fc blocking using a specific protein block (Novocastra), samples were incubated o/n with rat anti-mouse IL-10 Ab followed by the Alexa 488 goat anti-rat Ab. Subsequently, slides were incubated with anti-mouse CD45RA Ab and marked by the Alexa 568 goat anti-mouse Ab.
Statistical analysis
Experimental data are shown as means 6 SEM. Unpaired or paired Student t tests (Prism GraphPad Software) were used to analyze the results for statistical significance. The p values ,0.05 were considered significant.
Results
MCs promote the expansion in vitro of IL-10-competent B cells
To assess the ability of MCs to influence the expansion of IL-10-competent B cells, we cocultured murine BMMCs and splenic B cells at a 1:1 ratio for 48 h. To induce cytoplasmic IL-10 production in IL-10-competent B cells and block protein secretion, we added a mixture of LPS, PMA, ionomycin, and monensin (LPIM) to the coculture 5 h before cell harvesting. Compared with The Journal of Immunologyfreshly isolated B lymphocytes, the proportion of B cells competent to express cytoplasmic IL-10 after LPIM stimulation was significantly increased after coculture with MCs (Fig. 1A) . Coculture of B lymphocytes with non-IgE-sensitized or IgE-Agstimulated MCs increased the proportion of IL-10 + B cells to 8.4% (60.9) and 7.1% (60.8), respectively, an ∼2.5-fold increase with respect to the pre-coculture condition (2.9 6 0.2%). Both in freshly purified B cells and in B-MC cocultures, no cells positively stained for IL-10 were detected without the 5-h addition of LPS plus PMA and ionomycin (Supplemental Fig. 1 ).
To test whether the observed increase of IL-10-competent B cells might be driven through enhanced and selective proliferation induced by MCs, we labeled B lymphocytes with the CPD and cocultured them with non-IgE-sensitized MCs for 72 h. As shown in + B-1a and CD1d hi CD5 + B10 cells (11, (19) (20) (21) . To address the phenotype of IL-10-competent splenic B cells obtained after coculture with MCs, we analyzed B cells within both the IL-10 + and the IL-10 2 gates for CD1d and CD5 expression, because their differential expression allows us to distinguish distinct subsets of regulatory B cells (Bregs) described in the literature (11) . IL-10-competent B cells induced by non-IgEsensitized MCs were found within all the four subsets defined by the differential expression of the aforementioned markers. The highest proportion of these cells (51.1 6 3.6%) expressed high levels of CD1d and low levels of CD5, thus resembling the phenotype of MZ or T2-MZP B cells ( Fig. 2A) . Only a small proportion of total IL-10 + B cells were CD1d + CD5 + (7.7 6 1.1%) or CD1d 2 CD5 + (4.3 6 1.1%). In contrast, the majority of IL-10 2 cells expressed low levels of both CD1d and CD5. Because CD21 and CD23 are commonly used to distinguish MZ from follicular and transitional B cells (22, 23) , we further analyzed the expression levels of these markers on IL-10 + B cells after coculture with MCs. As shown in Fig. 2B , the majority of IL-10 + B cells expressed high levels of CD19 and CD21 and were CD23 + , further supporting the evidence that these cells are phenotypically similar to T2-MZP B cells.
The CD40L/CD40 axis contributes to MC-driven expansion of IL-10-competent B cells
Both cell-cell contacts and cytokines secreted by MCs could be responsible for the expansion of IL-10-competent B cells. To test the relative contribution of both components, we performed a coculture transwell assay. As shown in Fig. 3A , when the two populations were physically separated, a partial but significant decrease was observed in the proportion of IL-10 + B cells. The coculture with non-IgE-sensitized MCs induced 8.1% (6 0.9) IL-10-competent B cells, whereas only 6.7% (61.0) of the B cells were IL-10 + in the presence of the transwell. Similar results were seen when MCs were stimulated with IgE-Ag. These findings suggest that cell contacts contribute to the expansion of IL-10-competent B cells, but also imply that soluble factors are involved.
We next explored which membrane molecules might be involved in promoting IL-10-competent B cell expansion. MCs express several costimulatory molecules, many of which are known to modulate B cell activation and function. CD40L is constitutively expressed on the surface of MCs (Fig. 3B) , and we previously showed that its interaction with CD40 on B cells is important for MC-driven proliferation of B cells and for their differentiation into plasma cells (13) .
To evaluate whether the CD40L/CD40 axis is involved in the physical interaction between MCs and B cells, we observed cell-cell interactions by real-time imaging. Time-lapse brightfield video microscopy showed that MC-B cell conjugates were formed after only few minutes of coculture (Fig. 3C ). Interestingly, when MCs were derived from Cd40l 2/2 mice, the number of conjugates was drastically reduced compared with WT MCs. As soon as 1 min after coculture, the proportion of Cd40l 2/2 MCs making contacts with B cells was 5-fold less than that of WT MCs, and this defect in interaction continued for at least 20 min of observation. These findings suggest that the presence of CD40L on MCs is crucial for the formation of cell-cell contacts with B cells. Given the importance of the CD40L/CD40 axis in B-MC interaction, we analyzed its contribution to the expansion of IL-10-competent B cells. In the presence of an anti-CD40L blocking Ab, a significant decrease in the proportion of CD19 + IL-10 + cells was observed (Fig. 3D ). This reduction was ∼30% and occurred with both non-IgE-sensitized and IgE-Ag-stimulated MCs. To further validate these findings, we used Cd40l 2/2 BMMCs to perform the B-MC cocultures. As shown in Fig. 3E , in the presence of nonIgE-sensitized or IgE-Ag-stimulated Cd40l 2/2 MCs, the proportion of CD19 + IL-10 + cells was, respectively, 5.3 (6 1.2) and 4.8% (6 1.3), ∼20% lower than for B lymphocytes incubated with WT MCs.
CD40L-exosomes contribute to MC-driven expansion of IL-10-competent B cells
In addition to the expression of cell-surface costimulatory molecules, MCs produce exosomes (Fig. 4A) , whose content is quite heterogeneous (24, 25) . It has been previously shown that MCs can communicate with B cells through the secretion of these small, diffusible vesicles that induce B cell proliferation and activation (26, 27) . Because CD40L is a prominent component of MC-derived exosomes (27) , the possible role of exosomes in the expansion of IL-10-competent B cells was investigated.
MCs and B cells were cultured either alone or together for 48 h. Exosomes were isolated from conditioned media (CM) and analyzed by flow cytometry. As shown in Fig. 4B , both MCs and B cells released exosomes. As expected, CD9 (a characteristic exosome marker) was detected on both MC-and B cell-exosomes, whereas CD40L was found only on MC-secreted exosomes. Interestingly, supernatants from B-MC cocultures showed less detectable exosomes, and those present did not express CD40L at the levels seen in exosomes derived from cultures of MCs alone (Fig. 4B) . In light of these results, we quantified the proportion of IL-10-competent B cells when B lymphocytes were cultured for 48 h with MC-CM in the presence or absence of an anti-CD40L blocking Ab. Indeed, when B cells were cultured with non-IgEsensitized MCs supernatants, the proportion of CD19 + IL-10 + cells was 2.6-fold higher than that seen in the nontreated B cell population (Fig. 4C) . When the anti-CD40L blocking Ab was added to MC-CM and cultured with B cells, a significant reduction (25%) in the proportion of CD19 + IL-10 + cells was observed relative to B cells cultured in MC-CM.
MCs influence IL-10-competent B cell differentiation in vivo
Next, we explored in vivo whether MCs play a role in the differentiation of IL-10-competent B cells. To do so, we used the C57BL/6-Kit W-sh/W-sh (Kit W-sh ) murine model of MC deficiency, which enabled us to investigate whether the congenital deficiency of MCs could affect the proportions of IL-10-competent B cells in various lymphoid organs. We analyzed the percentage of IL-10-competent B cells in the bone marrow, lymph nodes, peritoneum, and spleen, which are all known to be important sites of B cell differentiation, maturation, and activation, and we compared them with control C57BL/6 (B6) mice. After stimulation with LPIM for 5 h, CD19 + IL-10 + cells were found in all the organs studied of both MC-deficient and -sufficient mice (Fig. 5) . In the spleen, the IL-10-competent B cell population seemed not to be affected by the absence of MCs because no significant differences were observed between B6 and Kit W-sh mice (Fig. 5A ). In the bone marrow (Fig. 5B) , the percentage of CD19 + IL-10 + cells was 30% lower in Kit W-sh than in WT mice, but this difference was not statistically significant. In the peritoneum (Fig. 5C ) and lymph nodes (Fig. 5D) , MC-deficient Kit W-sh mice had significantly lower proportions (a 36 and 33% reduction, respectively) of IL-10-competent B cells than WT controls.
To test whether the observed differences in the percentages of IL-10-competent B cells between B6 and Kit W-sh mice were truly due to the absence of MCs, we reconstituted Kit The different response of peritoneal B cells to MCs could be because of the specific and peculiar properties of the different B cell subsets present in this site, and because of their different and selective capacity to respond to MC-driven stimuli. The peritoneal cavity is characterized by the presence of two distinct B cell populations, B-1 and B-2, which differ for their developmental origin, anatomical localization, and functional characteristics (28) . Therefore, we next investigated whether the different B cell subsets present in the peritoneal cavity responded differently to MCs, in terms of IL-10 competence. The partially purified peritoneal B cell population was cultured for 48 h with MCs. Then IL-10-competent B cells were quantified after the 5-h in vitro stimulation with LPIM, and the anti-CD5 or anti-CD23 Abs were added to the cell-surface staining mixture to distinguish B-1a (CD5 (29), we observed that the percentage of B lymphocytes induced to produce IL-10 was higher among B-1a compared with B-1b and B-2 cells (Fig. 6B, 6C, left panels) . Interestingly, the coculture with MCs led to a reduction of the percentage of B cells that responded microenvironment was due to the fact that the colon represents an anatomical site in which the B-MC interaction is likely to occur (Supplemental Fig. 3 ), especially in an inflammatory setting (13) . Moreover, the differentiation of Bregs actively producing IL-10 has been described in this organ (30) .
First, we confirmed the ability of MCs to affect IL-10-competent B cells in a normal intestinal microenvironment. Although in this condition the proportion of CD19 + IL10 + cells present among the enriched lymphocyte population of the colonic LP is lower compared with other mouse organs, MCs were still able to augment the percentage of IL-10-competent B cells in a 48-h coculture assay. After the 5-h in vitro stimulation with LPIM, only 0.8% of the B cells present among the enriched lymphocyte population of the LP responded expressing IL-10, but this percentage is doubled after coculture with MCs (Fig. 7A) . This in vitro finding was further validated by looking at the presence of IL-10-producing B cells in colon sections of WT and Kit W-sh mice by in situ double immunofluorescence. As a control, the same experiment was performed in specimens of Kit W-sh mice that were i.p. reconstituted with WT MCs and in which MC reconstitution was checked by analyzing the distribution of MCs in the colon 8-10 wk after adoptive transfer of BMMCs (Supplemental Fig. 4 ). As shown in Fig. 7B , WT mice had more B cells positively stained for IL-10 compared with Kit W-sh mice. Reconstitution of Kit W-sh mice with WT BMMCs significantly increased the number of IL-10-producing B cells relative to Kit W-sh mice, but it did not completely restore the number of such cells to the levels of WT mice.
Interestingly, the same effect was not obtained by reconstituting Kit W-sh mice with Cd40l 2/2 BMMCs, further supporting the evidence that MC-provided CD40L is an important poising signal for IL-10 competence in B cells. We then examined the effect of the absence of MCs on IL-10-producing B cells in the context of DSS-induced intestinal inflammation. Yanaba and coworkers (31) have previously shown that during DSS-induced intestinal injury, IL-10 expression was enhanced in splenic B cells, but not in B cells from the intestinal LP. Accordingly, we found a higher number of B cells positively stained for IL-10 in colon samples of untreated WT mice than of WT mice sacrificed in the acute phase of inflammation that is 10 d after initiation of DSS administration (day 10). This result was not dependent on MCs because the same outcome was observed also in Kit W-sh mice (Fig. 7C, upper and middle panels) . Interestingly, the number of IL-10-producing B cells began to increase in WT mice 7 d after DSS withdrawal (day 17), suggesting that this Breg population might be expanded in the colon or recruited from other anatomical sites during the recovery phase to resolve inflammation. Notably, this process was dependent on MCs because no increase was observed at day 17 in colon samples of Kit W-sh mice (Fig. 7C, lower panels) .
Discussion
It is now widely accepted that B cells can exert a regulatory role in autoimmunity, inflammation, and infection, and that IL-10 production is pivotal to Breg-mediated tolerance (11) . B cells that produce IL-10 are found at different anatomical sites where they exert their suppressive function after encountering an appropriate and context-specific signal. This response can be mimicked in vitro by the short-term stimulation with LPS, PMA, and ionomycin, which promotes Il-10 expression only in poised B cells already competent for cytokine production, allowing their detection ex vivo (10) . Over the past decade, a considerable effort has been made toward identification of signals that induce IL-10- + cells for one of two independent experiments. B cells stained for IL-10 were detected and counted out of four 3400 high-power microscopic fields in each case. *p , 0.05. (B and C) Slides were evaluated using a Leica DMI6000 microscope, and microphotographs were collected using a Leica DFC350FX digital camera. Original magnification 3200. Red represents CD45R; green represents IL-10. competent B cells in vivo (12) . Nonetheless, little is known about how the cell types promote IL-10-competent B cell expansion.
In this article, we show that MCs contribute to the expansion of IL-10-competent splenic B cells in vitro. The proportion of CD19 + IL-10 + cells was significantly increased after culturing B cells with MCs, and proliferation assays demonstrated that MCderived signals promote the preferential proliferation of IL-10-competent B cells with respect to other B cell subsets. However, a process of de novo differentiation of IL-10-competent B cells cannot be excluded. Although MCs induced the expansion of IL-10-competent B cells, they did not enhance the overall production of the cytokine. IL-10 mRNA and protein levels in B lymphocytes were not increased in the presence of MCs. This is not unexpected because the expansion of IL-10-competent B cells and the production of IL-10 are two distinct processes, differentially regulated. A superb example comes from direct CD40 activation of B cells: although CD40 signaling promotes an increase in the proportion of IL-10-competent B cells, it does not itself induce IL-10 secretion (32) . Thus, consistent with our findings, the signals provided by MCs seem to be preparatory in nature, instructing the B cell to become competent for a suppressive function when encountering an appropriate and context-specific second signal.
We show that CD40L on MCs is important for IL-10-competent B cell expansion because the presence of anti-CD40L blocking Ab or of Cd40l 2/2 MCs led to a significant reduction of CD19 + IL-10 + cells in the cocultures. However, it is also clear that other membrane-bound or soluble factors are likely to contribute to this expansion. MCs release cytokines known to affect important physiological functions such as B cell growth, differentiation, and Ig class switching (33, 34) . Moreover, MCs can release leukotriene B 4 , to which it has recently been attributed a role in the generation of tumor-evoked Bregs (35) . These multiple factors constitute fertile ground for further investigation. The role of exosomes in cell-cell communication is noteworthy (36) , and the finding that MCs produce exosomes suggests that this may be an important mechanism by which MCs communicate to other cells. Importantly, we show that MC-derived exosomes express CD40L and contribute to the expansion of IL-10-competent B cells. Taking advantage of the Kit W-sh murine model of MC deficiency, we investigated the role of MCs on IL-10-competent B cell differentiation and maturation in vivo. If on one hand our results argue that MCs are involved in these processes (Kit W-sh mice had significant lower percentages of CD19 + IL-10 + cells in the colon, peritoneum, and lymph nodes compared with WT mice), then on the other hand they revealed the complexity of the in vivo regulation of IL-10-competent B cell differentiation, which appeared to be tissue specific. No differences were observed in the spleen, a site in which B-MC interactions are less likely and where other immune cell types may play specific inductive functions, compensating the role of MCs. The IL-10-competent B cell deficiency in the peritoneum of Kit W-sh mice is peculiar in that MC reconstitution in adult mice does not restore normal percentages of these cells. This difference is not due to the selective sensitivity of the B-1 versus the B-2 cell subsets to MCs because B cells that belong to both subsets appear insensitive to the inductive signals from MCs. Given the developmental features of this immunological site (the peritoneum is populated early during ontogenesis and the resident B cell population is mainly self-replenishing) (37) , it is still possible that MCs influence the development of IL-10-competent B cells earlier in life and that the deficiency observed in adult Kit W-sh mice is the result of a defect during ontogenesis. Nonetheless, once B cells have developed and established themselves in the peritoneum, their interaction with MCs does not lead to the expansion of IL-10-competent B cells. Thus, the cross talk between peritoneal B cells and MCs appears to produce different effects compared with the other organs analyzed. Again, this probably reflects the peculiar immunological features of this compartment and the specific functions of peritoneal MCs and B cells within.
Finally, we observed that the IL-10-producing B cell population is significantly reduced in the colon of Kit W-sh mice and that the population of IL-10-competent B cells resident in the LP responds to the inductive signals of MCs as CD19 + IL10 + cells are expanded when cocultured in vitro with MCs. Moreover, MCs could play a role in expansion of IL-10-competent B cells resident in the LP and/or in the recruitment of circulating IL-10-competent B cells to this site because in Kit W-sh mice we did not observe an increase of these cells during the resolution phase of DSS-induced intestinal inflammation. The function of IL-10-producing B cells in this organ represents a key mechanism for the maintenance of gut homeostasis and for the control of the immune response against Ags (38) . MC regulation of IL-10-competent B cells in the colon contributes to this homeostatic process, and the alteration of this mechanism could play a role in pathological conditions such as chronic inflammation and cancer.
In conclusion, for the first time, to our knowledge, we provide the evidence of a complex cross talk between MCs and B cells that is important for the expansion and differentiation of IL-10-competent B cells. We show that MCs are able to modulate the IL-10-competent B cell population according to the specific tissue microenvironment, and we provide evidence that in the absence of MCs the proportions of IL-10-competent B cells are significantly reduced in several immunological sites, both under homeostatic conditions and at resolution of inflammation.
